nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Hypomagnesaemia—Vandetanib—thyroid cancer	0.0883	0.0883	CcSEcCtD
Capreomycin—Hypocalcaemia—Vandetanib—thyroid cancer	0.0613	0.0613	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—thyroid cancer	0.0519	0.0519	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—thyroid cancer	0.048	0.048	CcSEcCtD
Capreomycin—Hypocalcaemia—Sorafenib—thyroid cancer	0.0413	0.0413	CcSEcCtD
Capreomycin—Hypokalaemia—Vandetanib—thyroid cancer	0.0371	0.0371	CcSEcCtD
Capreomycin—Renal failure—Vandetanib—thyroid cancer	0.0308	0.0308	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—thyroid cancer	0.0253	0.0253	CcSEcCtD
Capreomycin—Hypokalaemia—Sorafenib—thyroid cancer	0.025	0.025	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—thyroid cancer	0.0238	0.0238	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—thyroid cancer	0.0234	0.0234	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—thyroid cancer	0.022	0.022	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—thyroid cancer	0.022	0.022	CcSEcCtD
Capreomycin—Renal failure—Sorafenib—thyroid cancer	0.0208	0.0208	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—thyroid cancer	0.0204	0.0204	CcSEcCtD
Capreomycin—Thrombocytopenia—Vandetanib—thyroid cancer	0.0196	0.0196	CcSEcCtD
Capreomycin—Tinnitus—Sorafenib—thyroid cancer	0.0177	0.0177	CcSEcCtD
Capreomycin—Abscess—Epirubicin—thyroid cancer	0.0177	0.0177	CcSEcCtD
Capreomycin—Pain—Vandetanib—thyroid cancer	0.0171	0.0171	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—thyroid cancer	0.0164	0.0164	CcSEcCtD
Capreomycin—Body temperature increased—Vandetanib—thyroid cancer	0.0158	0.0158	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—thyroid cancer	0.0153	0.0153	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—thyroid cancer	0.0152	0.0152	CcSEcCtD
Capreomycin—Leukopenia—Sorafenib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—thyroid cancer	0.0141	0.0141	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—thyroid cancer	0.014	0.014	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—thyroid cancer	0.014	0.014	CcSEcCtD
Capreomycin—Thrombocytopenia—Sorafenib—thyroid cancer	0.0132	0.0132	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0129	0.0129	CcSEcCtD
Capreomycin—Rash—Vandetanib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Capreomycin—Dermatitis—Vandetanib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Capreomycin—Pain—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Capreomycin—Urticaria—Sorafenib—thyroid cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Body temperature increased—Sorafenib—thyroid cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—thyroid cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Hypersensitivity—Sorafenib—thyroid cancer	0.00995	0.00995	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—thyroid cancer	0.00987	0.00987	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—thyroid cancer	0.00924	0.00924	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—thyroid cancer	0.00869	0.00869	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—thyroid cancer	0.00855	0.00855	CcSEcCtD
Capreomycin—Rash—Sorafenib—thyroid cancer	0.00851	0.00851	CcSEcCtD
Capreomycin—Dermatitis—Sorafenib—thyroid cancer	0.0085	0.0085	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—thyroid cancer	0.00804	0.00804	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—thyroid cancer	0.00769	0.00769	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—thyroid cancer	0.00712	0.00712	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—thyroid cancer	0.00655	0.00655	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—thyroid cancer	0.00606	0.00606	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—thyroid cancer	0.00549	0.00549	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—thyroid cancer	0.00547	0.00547	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—thyroid cancer	0.00508	0.00508	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—thyroid cancer	0.00506	0.00506	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—thyroid cancer	0.00489	0.00489	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00452	0.00452	CcSEcCtD
Capreomycin—Pain—Epirubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Capreomycin—Pain—Doxorubicin—thyroid cancer	0.00395	0.00395	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—thyroid cancer	0.00368	0.00368	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—thyroid cancer	0.00365	0.00365	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—thyroid cancer	0.0034	0.0034	CcSEcCtD
Capreomycin—Rash—Epirubicin—thyroid cancer	0.00315	0.00315	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Capreomycin—Rash—Doxorubicin—thyroid cancer	0.00291	0.00291	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—thyroid cancer	0.00291	0.00291	CcSEcCtD
